Notice of Intent to Sole Source – Illumina
Closed Special Notice Posted
- Solicitation number
- 26-005075
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- Place of performance
- Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health issued a notice of intent on May 1, 2026, to sole-source a maintenance agreement for the Illumina NextSeq 1000 Sequencing System to Illumina, Inc., with a response deadline of May 10, 2026. The acquisition is not subject to competition; NIH intends to award a firm fixed price purchase order directly to Illumina under FAR Part 13 Simplified Acquisition Procedures, citing the manufacturer as the sole reasonably available source for equipment serviced exclusively by the original equipment manufacturer. The equipment will be placed at the Department of Transfusion Medicine at the NIH Clinical Center in Bethesda, Maryland. Although this is a notice of intent and no solicitation document will be issued, interested parties may submit comments identifying their interest and capabilities; however, the Government reserves sole discretion to proceed with the sole-source award regardless of responses received.
Notice text
This acquisition is for a maintenance agreement for the Illumina NextSeq 1000 Sequencing System at the Department ofTransfusion Medicine (DTM) at the National Institutes ofHealth (NIH) Clinical Center (CC).
• Product Service Code: 6515 – Medical Instruments,Equipment, and Supplies
• NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing
• Place of Performance: Bethesda, MD 20892 USA
POTS: 26-005075
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award afixed price purchase order to Illumina, Inc., located at 5200 Illumina Way, San Diego, CA 92122, on a firm fixed price sole source award basis to provide the Illumina NextSeq 1000 Sequencing System at the National Institutes of Health, Department of Transfusion Medicine (DTM).
The instrument is manufactured and serviced by the vendor. The equipment is required by the original manufacturer (Illumina, Inc.) and it is therefore deemed to be in the Government’s best interest that this item is procured from the manufactuer.
This acquisition is being conducted using policies unique tothe Federal Acquisition Regulation (FAR) Part 13 – SimplifiedAcquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold(SAT), contracting officers may solicit from one source if thecontracting officer determines that the circumstance of thecontract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified AcquisitionProcedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested parties may identify their interest and capabili-ties in response to this posting. The determination by the Government not to compete the proposed requirementbased upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this postingnumber, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing datespecified in this announcement, to the attention of Gregory Noland, Contract Specialist via email to gregory.noland@nih.gov by May 10, 2026 at 1600 EST.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside | |
| Notice of Intent to Sole Source – Boston Scientific | NIH Clinical Center | No set-aside | |
| Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000 | Naval Supply Systems Command | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside | |
| Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000 | Naval Supply Systems Command | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity